Sign in
4

Changes in Ownership

Foghorn Therapeutics Inc. Filed Acc 0001562180-25-000504

Options or other derivatives

  • Chief People Officer acquired 115,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Costa Carlos Chief People Officer 2025-01-22 Grant or award · Stock Option (right to buy) +115,000 $4.37 $502,550 115,000 D
Loading xslF345X05/primarydocument.xml…